Meridian Bioscience Inc MR4-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 03/05/21 CET
17.40quote price arrow up+0.20 (+1.16%)
52 week range
5.05 - 25.00

...

Loading . . .

KEY STATS

  • Open17.40
  • Day High17.40
  • Day Low17.40
  • Prev Close17.20
  • 52 Week High25.00
  • 52 Week High Date02/15/21
  • 52 Week Low5.05
  • 52 Week Low Date03/13/20
  • Market Cap907.89M
  • Shares Out43.07M
  • 10 Day Average Volume982.73
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change128.95

RATIOS/PROFITABILITY

  • EPS (TTM)0.91
  • P/E (TTM)19.12
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/01/2019
  • Div Amount0.125
  • Split Date-
  • Split Factor-

Latest Meridian Bioscience Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic...
David Phillips CPA
Non-Executive Chairman
John Kenny
Chief Executive Officer
Bryan Baldasare
Chief Financial Officer
Lourdes Weltzien
Executive Vice President
Tony Serafini-Lamanna
Executive Vice President
Address
3471 River Hills Dr
Cincinnati, OH
45244
United States